Get in Touch
0
0
We Serve

Financial Services

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve
What we do

Select Capabilities

All Capabilities

Market Landscaping and Sizing

A winning strategy requires deep understanding of the size, growth, segmentation, competitive dynamics, and voice-of-customer in your markets. DeciBio has the qualitative and quantitative research and analysis capabilities to give you the insights you need.
View

Data Analytics

Use it or lose it. If you’re not leveraging your data to extract insights on your customers and market, you’re falling behind. We’re here to help with bespoke data services.
View

Pricing Strategy

Precise pricing is critical to realizing maximum adoption and market value. DeciBio takes a multi-pronged approach to triangulate optimal price points for your products and services.
View
Impact

Selected Work

All Work
Financial Services
PE-Backed Life Sciences Tools Platform Development
A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform
View
Voice-of-Customer Research
Customer Segmentation
Pricing Strategy
Due Diligence
Competitive Analysis
Financial Services
Investment Diligence into Leading Oncology Diagnostic Provider
A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment
View
Voice-of-Customer Research
Competitive Analysis
Revenue Projection
Due Diligence
Financial Services
High-Level Commercial Due Diligence in Digital Pathology
An early-stage venture firm requested a high-level commercial due diligence of a potential investment
View
Due Diligence

Featured Team

Stephane Budel

Founding Partner

David Cavanaugh

Founding Partner

Andrew Aijian

Partner

Miguel Edwards

Partner

Carl Schoellhammer

Partner
Data & Platforms

Data & Platforms

See all

Global In Vitro Diagnostics Market Report, First Edition: 2025-2030 - Coming Soon!

We’re pleased to announce the upcoming publication of DeciBio’s inaugural Global In Vitro Diagnostics Market Report, First Edition: 2025-2030, an in-depth, data-driven resource designed to support strategic decision-making in the IVD space.
Read More

Analytical Instrument Utilization Report

This report provides a summary of historical (2019-2025) and expected (2025-2027) analytical instrument use across academic core laboratories in the U.S., Europe, and APAC.
Read More

Pharma CDx Development and Commercialization Ad Board

DeciBio conducted 25 interviews with stakeholders at pharmaceutical companies to better understand their perspectives on Companion Diagnostic (CDx) development and commercialization.
Read More

Global Bioprocessing Market Report, First Edition: 2024-2027

This first edition provides an overview of the global bioprocessing market from 2024–2027, segmented into the manufacturer market and the CDMO/services market. The scope includes the production of biological therapeutics from cell-based systems (e.g., biologics, cell and gene therapies) across upstream and downstream workflows, while excluding stable cell line development, formulation, fill-finish, and QC / lot release testing.
Read More
Insights Blog

Related Insights

See all

Rethinking Cancer Screening in Europe: The Promise and Peril of MCED Testing

Read More

Digital Health and Informatics | August Round-Up 2025

Read More

AI / Machine Learning | August Round-Up 2025

Read More

Next-Generation Therapeutics | August Round-Up 2025

Read More
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions